Why the study?
Can macronodular and micronodular adrenocortical pathologies causing Cushing's syndrome be clinically differentiated?
Can macronodular and micronodular adrenocortical pathologies causing Cushing's syndrome be clinically differentiated?
MACRO-NAP and MICRO-NAP causing Cushing's syndrome are distinct clinical entities that can be differentiated by their phenotypic presentation.
Suggests phenotypic differentiation of MACRO-NAP and MICRO-NAP in Cushing's syndrome; hypothesis-generating and needs prospective validation.
Cushing's syndrome (CS) may be sustained by a nodular adrenocortical pathology (NAP) in addition to hyperplastic or neoplastic lesions of adrenal glands. NAP, in turn, may be represented by macronodular (MACRO) or micronodular (MICRO) manifestations. There is debate as to whether the MACRO-NAP and MICRO-NAP represent an expression of the same disorder or relate to distinguishable anatomo-clinical entities. A case of CS sustained by a "giant" MACRO-NAP forced use to review the literature and to analyze the morpho-clinical findings from a statistical viewpoint. Testing procedures were able to significantly dissect some clinical, pathological and hormonal characteristics. The statistical probation clearly indicated that MACRO-NAP and MICRO-NAP causing CS are nosologic entities that can be clinically differentiated via their phenotypic symptomatology.
No takes yet. Share an insight, caveat, or question.
Cugini et al. (1989) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: